News | October 01, 2008

Hologic’s CAD Could Improve Cancer Detection Rate in Mammography

October 2, 2008 - In a study that used Hologic’s R2 computer-aided detection (CAD) system, researchers found that “Single reading with computer-aided detection could be an alternative to double reading and could improve the rate of detection of cancer from screening mammograms read by a single reader.”

The study, which will published October 16, 2008 in The New England Journal of Medicine and was published in the online version of the Journal yesterday (http://content.nejm.org/cgi/content/full/NEJMoa0803545]), was a prospective, multi-center clinical trial, comparing the cancer detection rate for single reading of screening mammograms with CAD input versus double reading without CAD support.

Interpretation by two readers (double reading) rather than one reader is known to improve the cancer detection rate. The study’s authors stated that “Where single reading is standard practice, computer-aided detection has the potential to improve cancer detection to the level achieved by double reading.”

In the study, lead author Dr. Fiona Gilbert and her colleagues in the United Kingdom analyzed the screening results from 31,057 women undergoing routine screening by film mammography and found that a single reader with Hologic’s R2 CAD system produced comparable cancer detection rates (87.2 percent) to double reading (87.7 percent) without CAD. Although single reading with CAD produced a higher recall rate (3.9 percent) than double reading (3.4 percent), they concluded that despite this difference, “Single reading with computer-aided detection could be an alternative to double reading and could improve the rate of detection of cancer from screening mammograms read by a single reader.”

“Double reading is a method for increasing cancer detection commonly used in European screening programs. However, it is used by few practices in the United States because it is time-consuming and because of a shortage of radiologists focused on breast imaging,” said Ronald A. Castellino, MD, FACR, Chief Medical Officer for Hologic. “These results indicate that in the United States, where single reading of mammograms is most common, Hologic’s R2 CAD system can provide an improvement in cancer detection rates comparable to those achieved with double reading. This important study, combined with prior published research studies, further supports the use of the R2 CAD system to increase cancer detection.”

For more information: www.hologic.com

Related Content

Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing AI prod
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
QView Medical Showcases QVCAD for ABUS Exams at RSNA 2018
News | Ultrasound Women's Health | November 19, 2018
QView Medical will showcase QVCAD, the first U.S. Food and Drug Administration (FDA)-approved artificial intelligence (...
Lunit Unveiling AI-Based Mammography Solution at RSNA 2018
News | Mammography | November 15, 2018
Medical artificial intelligence (AI) software company Lunit will be returning to the 104th Radiological Society of...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...